Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: Insights from the Heart and Soul Study

Vascular Medicine (United Kingdom)

Volumn 18, Issue 4, 2013, Pages 176-184

  Grenon, S Marlene ^a,b   Vittinghoff, Eric ^c   Owens, Christopher D ^a,b   Conte, Michael S ^a   Whooley, Mary ^b,c   Cohen, Beth E ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

coronary disease; peripheral artery disease

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEALTH BEHAVIOR; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

CORONARY DISEASE; PERIPHERAL ARTERY DISEASE;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; TIME FACTORS;

EID: 84883038245     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X13493825     Document Type: Article

References (40)

1. Poredos P, Jug B.. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology. 2007 ; 58: 309-315
2. Dieter RS, Tomasson J, Gudjonsson T, et al. Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease. Vasc Med. 2003 ; 8: 233-236
3. Atmer B, Jogestrand T, Laska J, Lund F.. Peripheral artery disease in patients with coronary artery disease. Int Angiol. 1995 ; 14: 89-93
4. Cotter G, Cannon CP, McCabe CH, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003 ; 145: 622-627
5. Golomb BA, Dang TT, Criqui MH.. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006 ; 114: 688-699
6. Shah AM, Banerjee T, Mukherjee D.. Coronary, peripheral and cerebrovascular disease: a complex relationship. Herz. 2008 ; 33: 475-480
7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH.. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998 ; 97: 425-428
8. Ridker PM, Stampfer MJ, Rifai N.. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 ; 285: 2481-2485
9. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M.. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005 ; 96: 1374-1378
10. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG.. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation. 2005 ; 112: 976-983
11. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008 ; 300: 2379-2388
12. Ren X, Ristow B, Na B, Ali S, Schiller NB, Whooley MA.. Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease. Am J Cardiol. 2007 ; 99: 1643-1647
13. Asplund K, Bonita R, Kuulasmaa K, et al. Multinational comparisons of stroke epidemiology. Evaluation of case ascertainment in the WHO MONICA Stroke Study. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995 ; 26: 355-360
14. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M.. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995 ; 26: 361-367
15. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003 ; 108: 2543-2549
16. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007 ; 116: 2634-2653
17. Ali S, Garg SK, Cohen BE, Bhave P, Harris WS, Whooley MA.. Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: data from the Heart and Soul Study. Psychother Psychosom. 2009 ; 78: 125-127
18. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S.. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry. 2007 ; 62: 314-320
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC.. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 ; 28: 412-419
20. Dawson DA, Grant BF, Stinson FS.. The AUDIT-C: screening for alcohol use disorders and risk drinking in the presence of other psychiatric disorders. Compr Psychiatry. 2005 ; 46: 405-416
21. Gehi AK, Ali S, Na B, Whooley MA.. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2007 ; 167: 1798-1803
22. Bowles HR, FitzGerald SJ, Morrow JR, Jackson AW, Blair SN.. Construct validity of self-reported historical physical activity. Am J Epidemiol. 2004 ; 160: 279-286
23. Kurtze N, Rangul V, Hustvedt BE, Flanders WD.. Reliability and validity of self-reported physical activity in the Nord-Trondelag Health Study: HUNT 1. Scand J Public Health. 2008 ; 36: 52-61
24. Ainsworth BE, Jacobs DR, Leon AS.. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 1993 ; 25: 92-98
25. Aadahl M, Kjaer M, Kristensen JH, Mollerup B, Jorgensen T.. Self-reported physical activity compared with maximal oxygen uptake in adults. Eur J Cardiovasc Prev Rehabil. 2007 ; 14: 422-428
26. Jackson AW, Morrow JR, Bowles HR, FitzGerald SJ, Blair SN.. Construct validity evidence for single-response items to estimate physical activity levels in large sample studies. Res Q Exerc Sport. 2007 ; 78: 24-31
27. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999 ; 19: 538-545
28. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996 ; 25: 1172-1181
29. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH.. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993 ; 270: 487-489
30. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV.. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996 ; 313: 1440-1444
31. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 ; 326: 381-386
32. Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ.. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J Am Coll Cardiol. 1994 ; 23: 1091-1095
33. Jelnes R, Gaardsting O, Hougaard Jensen K, Baekgaard N, Tonnesen KH, Schroeder T.. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed). 1986 ; 293: 1137-1140
34. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004 ; 109: 733-739
35. Pasqualini L, Marchesi S, Vaudo G, et al. Association between endothelial dysfunction and major cardiovascular events in peripheral arterial disease. Vasa. 2003 ; 32: 139-143
36. Hussein AA, Uno K, Wolski K, et al. Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol. 2011 ; 57: 1220-1225
37. Welten GM, Schouten O, Hoeks SE, et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008 ; 51: 1588-1596
38. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006 ; 47: 1239-1312
39. Feringa HH, Karagiannis SE, van Waning VH, et al. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg. 2007 ; 45: 936-943
40. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004 ; 110: 227-239